Data / Form D filings / BlossomHill Therapeutics, Inc.
BlossomHill Therapeutics, Inc.: Form D filings
BlossomHill Therapeutics, Inc., a pharmaceuticals company in San Diego, CA, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on December 10, 2025, reports $84.2 million sold of a $84.2 million offering to 47 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10255 SCIENCE CENTER DRIVE, SUITE 200, San Diego, CA, 92121
- Phone
- (858) 732-3880
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1839970
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | New notice | $84,152,909 | $84,152,909 | 47 | Nov 25, 2025 | sec.gov | |
| Jan 2, 2024 | New notice | $99,999,997 | $88,649,917 | $11,350,080 | 44 | Dec 28, 2023 | sec.gov |
| Mar 1, 2021 | New notice | $70,999,993 | $70,999,993 | 27 | Mar 1, 2021 | sec.gov | |
| Jan 11, 2021 | New notice | $2,000,000 | $2,000,000 | 3 | Dec 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| GEORGE LEE | Director | |
| CARL GORDON | Director | |
| YISHAN LI | Executive Officer, Director | |
| SUNDEEP AGRAWAL | Director | |
| BIHUA CHEN | Director | |
| TIMOTHY STUBBS | Director | |
| JINGRONG JEAN CUI | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 8, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BlossomHill Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.